Key Takeaways
- Contract research labs and diagnostic testing facilities with documented client revenue qualify based on services income
- U Visa biotech entrepreneurs with advanced degrees and licensed lab operations qualify — no green card required
- Equipment, lab expansion, staffing, and working capital up to $5M
- SBA's 2026 citizenship rule blocked U Visa biotech operators from government-backed business financing
- 48-hour decisions using CRO contracts, client invoices, and bank statements
Biotech laboratory services economics divide between discovery-stage research (grant and equity funded) and revenue-generating contract services (CRO, diagnostic testing, analytical services). Contract research organizations (CROs) providing assay development, cell biology services, or analytical chemistry to pharmaceutical clients charge $2,000–$20,000 per project week. Clinical diagnostic laboratories processing 500 samples/day at $50 average generate $9.1M annually. Specialty analytical labs providing HPLC, mass spectrometry, or genomic sequencing services generate $1,000–$15,000 per analysis run. Immigrant scientists with advanced degrees from leading international universities represent a substantial portion of US biotech leadership, with many holding PhDs from institutions in India, China, Eastern Europe, and Latin America.
U Visa biotech business owners with documented CRO client contracts, laboratory service agreements, or diagnostic testing revenue have real, fundable businesses. Banks decline based on visa status. Bankable evaluates biotech service businesses on CRO contract revenue, diagnostic volume, equipment asset value, and client account documentation — the actual measures of laboratory business financial performance.
What Bankable Funds for Biotech Operators
- Laboratory equipment: Analytical instruments, bioprocessing equipment, imaging systems, and sequencing platforms
- Lab build-out: BSL-2 compliant laboratory construction, fume hoods, biosafety cabinets, and utility installation
- Scientist hiring: PhD scientists, laboratory technicians, and research associates to expand CRO capacity
- Reagents and consumables: Working capital for laboratory supplies against confirmed client project commitments
- CLIA certification: Investment for diagnostic laboratory certification and compliance infrastructure
CRO Contract and Diagnostic Revenue Underwriting
Bankable underwrites biotech service businesses using signed CRO master service agreements, diagnostic testing volume reports, client invoices, and six months of bank deposits. CRO labs with 5+ pharmaceutical or biotech clients on active project agreements qualify. Diagnostic labs with documented daily sample volume and payer mix provide strong revenue verification. Equipment appraisals for major instruments add collateral depth. Check your Bankability Score.
Laboratory equipment financing is the primary use case for biotech service firms: an LC-MS/MS system at $250,000 that enables metabolomics services at $3,000/sample generates compelling ROI. A next-generation sequencer at $150,000 that commands $1,500/sample enables a new service category with $500K+ annual revenue potential. Bankable evaluates biotech equipment on its revenue-generating capability. See our loan products overview.
Frequently Asked Questions
Yes. Bankable does not require citizenship. U Visa biotech business owners with valid work authorization, EINs, licensed laboratory operations, and documented client revenue qualify based on business performance.
Contract research organizations (CROs), clinical diagnostic laboratories, analytical chemistry labs, genomics and sequencing services, cell culture facilities, bioprocessing development labs, and specialty testing services.
Yes. Major analytical instrument purchases that expand laboratory service capabilities are primary biotech equipment financing use cases. We evaluate each instrument's projected revenue contribution alongside purchase cost.
U Visa biotech business operators are completely excluded from all SBA loan programs under the March 2026 citizenship mandate. Bankable's non-SBA model is fully available.
Six months of bank statements, 3–5 signed client service agreements or CRO contracts, most recent client invoices, laboratory license or CLIA certificate, and business registration.
Yes. CLIA certification costs — facility upgrades, proficiency testing enrollment, and compliance documentation — are eligible working capital uses for diagnostic labs seeking to expand testing menus.
We typically require $20K+/month in documented services revenue over at least 6 months. CRO labs with multiple pharmaceutical clients generating $100K+/month access larger initial tranches.
Yes. Labs transitioning from academic to commercial operations — with initial paying CRO clients — qualify for small initial tranches that grow as commercial revenue base develops.
Repayment is calibrated to project payment cycles — typically monthly amounts sized to 10–15% of average monthly client billing. Labs with milestone-based project payments can structure milestone-aligned repayment.
Your Bankability Score evaluates client revenue consistency, CRO contract coverage, equipment appraised value relative to revenue, staff credential depth, and laboratory compliance standing.